Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-20-026615

EVP and CFO sold 11,050 shares at an average $50.59 ($559,034)

  • EVP and CFO acquired 13,245 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ridloff Elena EVP and CFO 2020-04-29 Option exercise +10,000 $25.12 $251,200 10,000 D
Ridloff Elena EVP and CFO 2020-04-29 Sale −10,000 $50.74 $507,353 0 D
Ridloff Elena EVP and CFO 2020-04-29 Option exercise +3,245 3,245 D
Ridloff Elena EVP and CFO 2020-04-30 Sale −1,050 $49.22 $51,681 2,195 D
Derivatives
Ridloff Elena EVP and CFO 2020-04-29 Option exercise · Stock Option (Right to Buy) −10,000 35,547 D
Ridloff Elena EVP and CFO 2020-04-29 Option exercise · Restricted Stock Units −3,245 9,736 D
Open-market sales · 11,050 sh · avg $50.59 · $559,034
Loading xslF345X03/doc4.xml…